Advertisement
Screener

ZAI LAB LIMITED (ZLAB) Net Margin

Zai Lab Ltd Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Zai Lab Ltd net margin for the quarter ending 2026-06-30 was -48.06%, a change of -10.73% year-over-year.
  • Zai Lab Ltd net margin for the quarter ending 2026-03-31 was -53.39%, a change of -7.54% year-over-year.
  • Zai Lab Ltd net margin for the quarter ending 2025-12-31 was -39.66%, a change of 35.61% year-over-year.
  • Zai Lab Ltd net margin for the quarter ending 2025-09-30 was -31.17%, a change of 9.74% year-over-year.
  • Zai Lab Ltd net margin for fiscal 2025 was -38.40%, a change of 26.27% from fiscal 2024.
  • Zai Lab Ltd net margin for fiscal 2024 was -64.66%, a change of 60.80% from fiscal 2023.
  • Zai Lab Ltd net margin for fiscal 2023 was -125.46%, a change of 82.98% from fiscal 2022.
  • Zai Lab Ltd net margin for fiscal 2022 was -208.44%, a change of 280.42% from fiscal 2021.
Available history
2018-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2026-06-30-48.06%-$50.83M$105.75M
2026-03-31-53.39%-$51.02M$95.56M
2025-12-31-39.66%-$50.41M$127.09M
2025-09-30-31.17%-$35.96M$115.36M
2025-06-30-37.34%-$40.73M$109.09M
2025-03-31-45.85%-$48.44M$105.65M
2024-12-31-75.28%-$81.68M$108.51M
2024-09-30-40.92%-$41.67M$101.85M
2024-06-30-80.19%-$80.28M$100.11M
2024-03-31-61.36%-$53.47M$87.15M
2023-12-31-144.96%-$95.43M$65.83M
2023-09-30-99.89%-$69.15M$69.23M
2023-06-30-175.56%-$120.9M$68.86M
2023-03-31-78.26%-$49.14M$62.8M
2022-12-31-99.56%-$61.77M$62.04M
2022-09-30-282.97%-$161.19M$56.96M
2022-06-30-289.93%-$137.93M$47.58M
2022-03-31-178.75%-$82.39M$46.1M
2021-12-31-481.81%-$211.83M$43.96M
2021-09-30-223.68%-$96.41M$43.1M
2021-06-30-442.19%-$163.32M$36.94M
2021-03-31-1158.58%-$232.91M$20.1M
2020-12-31-507.14%-$76.55M$15.09M
2020-09-30-435.06%-$63.74M$14.65M
2020-06-30-733.32%-$80.63M$11M
2020-03-31-583.94%-$47.99M$8.22M
2019-12-31-999.52%-$46.43M$4.65M
2019-09-30-1328.66%-$65.37M$4.92M

Annual Net Margin

DateNet MarginNet incomeRevenue
2025-12-31-38.40%-$175.54M$457.18M
2024-12-31-64.66%-$257.1M$397.61M
2023-12-31-125.46%-$334.62M$266.72M
2022-12-31-208.44%-$443.29M$212.67M
2021-12-31-488.86%-$704.47M$144.11M
2020-12-31-549.26%-$268.91M$48.96M
2019-12-31-1502.28%-$195.07M$12.99M
2018-12-31-107810.08%-$139.08M$129,000.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67